The papain inhibitor (SPI) of Streptomyces mobaraensis inhibits bacterial cysteine proteases and is an antagonist of bacterial growth

12Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A novel papain inhibitory protein (SPI) from Streptomyces mobaraensis was studied to measure its inhibitory effect on bacterial cysteine protease activity (Staphylococcus aureus SspB) and culture supernatants (Porphyromonas gingivalis, Bacillus anthracis). Further, growth of Bacillus anthracis, Staphylococcus aureus, Pseudomonas aeruginosa, and Vibrio cholerae was completely inhibited by 10 μM SPI. At this concentration of SPI, no cytotoxicity was observed. We conclude that SPI inhibits bacterial virulence factors and has the potential to become a novel therapeutic treatment against a range of unrelated pathogenic bacteria. Copyright © 2013, American Society for Microbiology.

Cite

CITATION STYLE

APA

Zindel, S., Kaman, W. E., Fröls, S., Pfeifer, F., Peters, A., Hays, J. P., & Fuchsbauer, H. L. (2013). The papain inhibitor (SPI) of Streptomyces mobaraensis inhibits bacterial cysteine proteases and is an antagonist of bacterial growth. Antimicrobial Agents and Chemotherapy, 57(7), 3388–3391. https://doi.org/10.1128/AAC.00129-13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free